BasicFintech
Mainboard IPOupcomingBoth

G. Surgiwear IPO

G. Surgiwear IPO is a mainboard IPO scheduled to open for subscription on — and closed on —. The issue aggregates ₹740 Cr.

Price Band
TBA
GMP
Subscription
Listing

Overview

G. Surgiwear IPO is a mainboard IPO scheduled to open for subscription on — and closed on —. The issue aggregates ₹740 Cr.

IPO Details

G. Surgiwear IPO is a mainboard initial public offering scheduled to open for subscription on Both. The issue has a price band of TBA per equity share with a lot size of TBA shares, translating to a minimum retail investment of TBA.

The issue aggregates ₹740 Cr, and subscription dates are yet to be announced. Allotment is expected on and the equity shares are scheduled to list on .

Type
Mainboard
Status
upcoming
Price band
TBA
Face value
₹10 (typical)
Lot size
Min investment (Retail)
TBA
Issue size
₹740 Cr
Fresh issue
₹370 Cr
OFS
₹370 Cr
Exchange
Both
ISIN
TBA

Market Lot

Market lot details will be available once the price band and lot size are finalised in the Red Herring Prospectus.

IPO Reservation

Per SEBI guidelines, G. Surgiwear IPO reserves shares across investor categories as follows. Final allotment percentages may vary slightly based on the final issue document.

Category% ReservedNotes
QIB (Qualified Institutional Buyers)Not more than 50%Mutual funds, FIIs, banks, insurance
NII / HNI (Non-Institutional)Not less than 15%Bids ≥ ₹2 lakh
Retail (RII)Not less than 35%Bids up to ₹2 lakh

Important Dates

  1. Issue Open
    · Subscription opens
  2. Issue Close
    · Subscription closes
  3. Allotment
    · Basis of allotment finalised
  4. Refunds Initiated
    · Funds released for non-allottees
  5. Listing Date
    · Shares debut on the exchange

Grey Market Premium

Grey Market Premium for G. Surgiwear is yet to be tracked. We update GMP from multiple grey market sources during the subscription window. Bookmark this page and check IPO GMP Today for live updates.

Subscription Status

G. Surgiwear IPO subscription tracking will go live once the subscription window opens. Category-wise data (Retail / NII / QIB / Employee) will be available on IPO Subscription Status.

Allotment Status

G. Surgiwear IPO allotment will be finalised by the registrar (Bigshare Services) on . Check your allotment status using your PAN, application number, or DP ID via our allotment status checker or directly on the registrar's website.

If allotment fails, the blocked funds via ASBA / UPI mandate are released back within 24-48 hours. Applying through multiple demat accounts in family members' names improves chances on oversubscribed IPOs.

About G. Surgiwear

G. Surgiwear Limited, established in 1990, designs, develops and manufactures surgical consumables and implantable medical devices for hospitals, healthcare institutions, and surgical centres. The product portfolio spans orthopaedic implants (plates, screws, nails, prostheses), trauma + spine + joint-replacement implants, surgical consumables (sutures, drapes, gowns, instruments), and infection-control products. The Shahjahanpur (Uttar Pradesh) integrated manufacturing facility is supported by in-house R&D and advanced automated machinery — a vertically-integrated capability uncommon among Indian mid-cap medical-device manufacturers. The 35-year operating history provides multi-cycle business-cycle resilience and meaningful customer-validation track record across both private + government hospital procurement channels. Indian medical-devices manufacturing has been one of the structurally growing healthcare sub-segments through 2020-26. Demand drivers include domestic healthcare-infrastructure expansion (PMJAY hospital empanelment, AIIMS network expansion, state government hospital modernisation), import-substitution policy (PLI scheme for medical devices, BCD on imported implants, ICMR-driven domestic-clinical-trials encouraging Indian-manufactured devices), and rising orthopaedic + trauma procedure volumes driven by aging demographics + road-accident incidence. The ₹740 crore mainboard IPO is structured as ₹370 crore fresh + ₹370 crore OFS (50/50 split). DRHP filed; SEBI observations pending. Lead manager Motilal Oswal Investment Advisors + registrar Bigshare Services signal mainboard book-build setup.

Promoter & Holding Pattern

The promoter and promoter group hold the majority stake in G. Surgiwear prior to the IPO. Post-listing, this percentage will reduce as new equity shares are issued to the public. Detailed pre-IPO and post-IPO promoter holding data will be updated once the Red Herring Prospectus is finalised with SEBI.

Objects of the Issue

The G. Surgiwear IPO proceeds will be utilised across multiple strategic objectives. Typical objects include capital expenditure for expansion, repayment of debt, general corporate purposes, working capital, and OFS by selling shareholders. Detailed breakdown with amounts will be updated here from the Red Herring Prospectus.

Financial Performance

G. Surgiwear's three-year financials — revenue, PAT, assets, net worth — will be displayed here based on audited numbers from the Red Herring Prospectus. Year-on-year growth, EBITDA margins, debt-to-equity progression, and RoNW together form the basis for valuation comparison.

Valuation Snapshot

Key valuation metrics for G. Surgiwear — RoE, RoCE, EBITDA margin, PAT margin, debt-to-equity, EPS, P/E ratio, RoNW, NAV — will be updated based on FY25 numbers from the Red Herring Prospectus.

Peer Comparison

Listed peers in the Healthcare sector with key valuation metrics:

CompanyEPS (₹)P/E RatioRoNW (%)NAV (₹)Income (₹ Cr)
Poly Medicure
Krsnaa Diagnostics
Vishal Mega Mart / Hester Bio (medical-device adjacencies)

Anchor Investors

Anchor investor bidding for G. Surgiwear typically opens one working day before the issue opens to the public. Anchor investors — mutual funds, FIIs, sovereign wealth funds, and insurance companies — collectively subscribe to a portion of the QIB segment. Their participation signals institutional confidence. Anchor list and total amount will be updated once SEBI publishes the anchor filing.

Lead Managers (Merchant Bankers)

  • Motilal Oswal Investment Advisors

IPO Registrar

The registrar processes all bid applications, finalises the basis of allotment, manages refunds, and credits allotted shares to successful applicants' demat accounts.

Editorial Review

G. Surgiwear has filed DRHP for a ₹740 crore mainboard IPO — ₹370 crore fresh + ₹370 crore OFS (50/50 split). As of publication, exact dates, price band, and detailed financial granularity not yet announced. The business positioning is structurally attractive. 35-year operating history (established 1990) in surgical consumables + implantable medical devices is uncommon among Indian medical-device manufacturers — most peers are younger and lack the multi-cycle customer-validation track record. The Shahjahanpur integrated manufacturing facility with in-house R&D and automated machinery provides vertical-integration cost advantages over import-dependent peers. Indian medical-devices demand is supported by multiple structural tailwinds: PMJAY hospital network expansion + state hospital modernisation drives domestic procurement; PLI for medical devices + BCD on imports favours Indian manufacturers; aging demographics + road-accident incidence drive orthopaedic + trauma procedure volumes. Listed adjacencies (Poly Medicure for consumables, Krsnaa for diagnostics) trade at premium multiples on similar tailwinds. What's working: 35-year operating history provides multi-cycle resilience; vertical-integration at Shahjahanpur facility; structural medical-device demand tailwinds (PMJAY + PLI + demographics); 50% fresh-issue means meaningful capital reaches operating business; MOIA as BRLM signals institutional book-build expectation. What's concerning: 50% OFS structure means half of proceeds go to selling shareholders; substantial public-data gap on price band, dates, financial granularity, capacity utilisation; medical-device regulatory cycle (CDSCO + ICMR + state-FDA inspections) creates compliance overhead; competitive intensity rising as PLI attracts more entrants; orthopaedic implant pricing pressure under NPPA cap framework. Subscribe pre-RHP. 35-year operating history + vertical-integration + structural medical-device tailwinds + balanced 50/50 fresh-vs-OFS create credible mainboard thesis. Wait for RHP with financial granularity. Compare against Poly Medicure trailing multiples when announced. Sizing moderate (5-10% of healthcare thematic bucket) given pricing-cap risk and competitive expansion.

How to Apply for G. Surgiwear IPO

  1. Open broker app — Zerodha, Upstox, Angel One, Groww, 5paisa, ICICI Direct, or any other SEBI-registered broker. Navigate to the IPO section.
  2. Select G. Surgiwear IPO during the bidding window ().
  3. Enter bid details — minimum TBA shares per lot. Retail investors are recommended to bid at cut-off price (upper band).
  4. Submit UPI ID linked to a SEBI-approved bank.
  5. Approve UPI mandate from your UPI app within the deadline. Bid amount is blocked, not debited.
  6. Await allotment on .
  7. Listing day — shares list on Both on .

Risk Factors

1. 50% OFS structure — half of proceeds go to selling shareholders rather than operating business. 2. NPPA pricing-cap framework for orthopaedic implants — periodic price-cap revisions compress affected-product margins. 3. Medical-device regulatory cycle — CDSCO + ICMR + state-FDA inspections create compliance overhead. 4. Competitive intensity rising — PLI scheme attracting more entrants into medical-device manufacturing. 5. Substantial public-data gap on price band, dates, financial granularity, capacity.

G. Surgiwear IPO — FAQs

What is G. Surgiwear IPO?
G. Surgiwear IPO is a mainboard initial public offering listing on Both. The issue opens on — and closes on — with a price band of TBA per share.
What is the G. Surgiwear IPO price band?
The price band for G. Surgiwear IPO is TBA per equity share of face value ₹10 (typical). Retail investors are recommended to bid at the upper band (cut-off price).
What is the G. Surgiwear IPO lot size?
The minimum lot size for G. Surgiwear IPO is TBA shares per application. Minimum retail investment at the upper price band works out to approximately TBA.
When is the G. Surgiwear IPO opening date?
G. Surgiwear IPO opens for subscription on — and closes on —.
When is the G. Surgiwear IPO allotment date?
Basis of allotment is expected on —. Check your status on Bigshare Services's website using your PAN.
When is the G. Surgiwear IPO listing date?
G. Surgiwear shares are expected to list on Both on —.
What is the GMP of G. Surgiwear IPO?
GMP for G. Surgiwear is not currently tracked.
Who is the registrar of G. Surgiwear IPO?
Bigshare Services is handling allotment, refunds, and dematerialisation for G. Surgiwear IPO.
How can I apply for G. Surgiwear IPO?
Apply via any SEBI-registered broker (Zerodha, Upstox, Angel One, Groww, 5paisa, ICICI Direct) during the open window. Use UPI mandate or ASBA for fund blocking. Bid at cut-off for retail category.
What is the minimum investment?
Minimum retail investment is approximately TBA (1 lot × TBA shares at upper band).
Should I apply for G. Surgiwear IPO?
Whether to apply depends on your goals, risk appetite, and the company's fundamentals. Review the RHP, compare valuation with peers, and consult a SEBI-registered advisor.
What happens if my allotment fails?
Bid amount blocked via UPI/ASBA is released back within 24-48 hours. Apply through multiple family demat accounts to improve odds on oversubscribed issues.

Information shown is for educational purposes and does not constitute investment advice. GMP values are unofficial estimates from informal grey market sources. Please read the offer document (Red Herring Prospectus) carefully before investing.

Data sourced from NSE, BSE, the issue's registrar, and public filings. BasicFintech is not affiliated with the issuing company, its underwriters, or the exchanges.

GMP TodayAllotmentOpen Demat